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Respiratory illnesses account for an estimated 4 million deaths
each year, with a further 8 - 10 million children having related
morbidity annually.1 Respiratory syncytial virus (RSV) has been
recognised as the commonest aetiological agent for acute lower
respiratory tract infections (LRTI) in the developed world. In
the USAalone it accounts for 50 - 80% of all cases of
bronchiolitis, 91 000 paediatric hospitalisations and 4 500
deaths annually.2 In developing countries there are scant data
on the role of RSV in bronchiolitis. A study from the National
Institute of Virology in South Africa between 1990 and 1996
revealed a hospital-based incidence of between 3% and 18%,
mortality rates of between 12% and 43%, and morbidity rates
of between 27% and 96%. 3 Prematurity with or without chronic
lung disease and age less than 1 year have been associated
with increased severity of disease.4,5 Low socio-economic status,
ethnicity and maternal RSV antibody levels have not
consistently been shown to increase risk. 6 Hussey et al.7 failed
to identify any differences in the clinical presentation of
children with or without RSV acute LRTI.
Recent evidence has confirmed the role of cytotoxic T-
lymphocyte (CTL) responses to viral infections in animal
models.8 Mice with suppressed CTL responses had severe
disease and poor outcomes when exposed to the influenza
virus. Studies of CTL responses in adults infected with RSV
have shown exaggerated responses in specific peptides. 9,10
Evidence suggests that T and B cells, cytokines (interleukin
(IL)8 and IL2) and human neutrophil elastase play a significant
role in the pathogenesis of bronchiolitis.9-11 Elevated levels of
CD23 + B cells, immunoglobulin E (IgE) and RSV-specific IL4
responses have been demonstrated, but treatment with an IL12
antagonist has not been beneficial.10 RSV CTL responses have
not been tested in children with acute bronchiolitis. We
therefore conducted a study to determine the pathogenic role
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Background. Risk factors for admission of children with acute
bronchiolitis have remained controversial. Technological
advances in the measurements of cytotoxic T-lymphocyte
(CTL) activity, enable respiratory syncytial virus (RSV)-
specific CTLactivity to be studied in infants with
bronchiolitis for the first time. We evaluated risk factors for
admission of children with acute bronchiolitis and
determined the role of CTL responses in those infected with
RSV.
Method. Children between 3 and 24 months of age presenting
with bronchiolitis to the paediatric outpatient department at
King Edward VIII Hospital, Durban, over a 1-year period
were enrolled. Management included clinical evaluation,
nasopharyngeal aspiration, standard treatment and
hospitalisation if indicated. Secretions were tested with
monoclonal antibodies for RSV and pooled respiratory
viruses; shell vial cultures were also established. Permission
was requested from parents of RSV-infected subjects for blood
draws for specific cytotoxic T-cell assays and CD4/CD8 cells
on admission and repeat CTL on day 7.
Results. Viruses were identified in 55 of the 114 subjects
studied (48.2%). RSV was seen in 41 cases (74.5%). Twenty-
three infants (20.2%) required admission. Risk factors
associated with inpatient admissions on univariate analysis
included younger mean age (7.6 months v. 10.1 months),
overcrowding (p < 0.01) and indoor exposure to products of
combustion of cooking fuels (p = 0.05). Only the former two
were significant on multivariate analysis. RSV-specific CTL
responses were obtained in 21 children (51.2%). Responses
were either very weak (N = 7) or negative (N = 14) on day 0
and did not alter significantly on day 7. The mean CD4/CD8
ratios in this group were 2.27:1. The highest frequency of CTL
was directed against the proteins ‘M4/5/6’, with counts
ranging from 100 to 400 spot forming cells (sfc)/million.
Conclusion. Measures to address risk factors identified in this
study may decrease the need for hospitalisation from
bronchiolitis. The lack of RSV-specific CTL responses in
peripheral blood of immunocompetent RSV-infected children
suggest an alternative method of induction of immunity or
compartmentalisation of immune cells.
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of RSV-specific cytotoxic T-cell responses in peripheral blood in
these children. We evaluated factors that could be related to the
need for hospitalisation.
Patient details
This study was conducted over a 1-year period between June
1999 and May 2000. Children aged 3 - 24 months with
bronchiolitis who presented to the paediatric outpatient
department, King Edward VIII Hospital, Durban, were
recruited between 08h00 and 16h00 on weekdays. Informed
consent was obtained from parents or guardians of subjects.
Bronchiolitis was defined in accordance with international
diagnostic criteria.12 Children with asthma, chronic neurological
deficits, severe malnutrition and other co-morbid illnesses or
those in respiratory failure were excluded. Ethical approval for
the study was obtained from the University of Natal.
A detailed questionnaire on patient demographics, birth
details, feeding practices, home and family size, immunisations
or family history of related illness, pollutant exposure and
family order, was administered. Temperature, pulse oximetry,
and respiratory and heart rate evaluations were conducted at
two time points during physical examination.
Virus identification
Nasopharyngeal aspirates utilising an internationally accepted
technique13 were obtained and samples were transported
immediately in viral transport medium to the virology
laboratory at the University of Natal. For rapid viral diagnosis
monoclonal antibodies against RSV (Davies Diagnostia, Calif.)
and other pooled respiratory viruses, viz. influenzae A and B,
adenovirus, parainfluenza 1, 2, 3 and mumps were used in an
immunofluorescent assay. Shell vial cultures using A549 lung
tissue carcinoma for RSV and adenovirus, and monkey kidney
cell lines (vk) for pooled respiratory viruses were also
performed. Permission was requested from parents/guardians
of RSV monoclonal antibody-positive children to draw blood
for RSV-specific cytotoxic T-cell assays and CD4/CD8 cells on
admission and for repeat CTLon day 7.
Lymphocyte isolation
The heparin-anticoagulated blood was diluted 1:1 with 0.1%
fetal calf serum (FCS) RPMI, layered onto Ficoll Hypaque
(Histopaque, Sigma-Chemicals, St. Louis, Mo, specific gravity
1.007 g/cc) and centrifuged at 400 rpm for 25 minutes at room
temper a t u re. The mononuclear cell layer was removed, washed
twice with 0.1% FCS/RPMI 1640 (GIBCO-BRL, USA), 
counted, and tested for viability using trypan blue staining. The
cells were then resuspended in complete RPMI (10% FCS, 10 mM
L-glutamine, 10 mM herpes, penicillin/streptomycin  50 U).
RSV-specific CTL stimulation assay
Overlapping peptide sequences (10 - 20 mers) spanning the
RSV proteins NP, M, SH,  S and F were synthesised. These
peptides have been shown previously to elicit RSV-specific
CTLactivity as detected by the elispot assay.13 Microtitre plates
(Millipore) were pre-coated with anti-gamma-interferon for 24
hours and thereafter washed with 0.1% BSA/0.5% FCS in
phosphate-buffered saline (PBS). Fifty thousand peripheral
blood mononuclear cells (PBMCs) per well were incubated
with each peptide overnight. The plates were then washed
with PBS and biotinylated anti-gamma interferon was then
added for 100 minutes. This was followed by the addition of
streptavidin/alkaline phosphatase conjugate for 30 minutes.
The substrate bromochloroiodyl phosphate (BCIP) was then
added and nitroblue tetrazolium chloride was used as the
colour reagent. The presence of blue spots indicated gamma-
interferon production and positive CTLactivity. The well with
the highest frequency of CTLs indicated the responses to the
immunodorminant peptide. Results were reported as spot
forming cells (sfc) per million PBMC.
Management of enrolled subjects included the use of
bronchodilators, humified oxygen, antibiotics, antipyretics and
decongestants.  Children with poor feeding, listlessness, falling
oxygen saturation and increasing respiratory distress were
considered to have inadequate clinical response and to need
hospitalisation. Admissions had blood and nasal samples s e n t
for bacterial isolation. Children were followed up on day 7.
Results
Of the 114 children enrolled in the study, 23 (20.2%) required
hospitalisation. One hundred and four (91.2%) of all subjects
studied were less than 1 year of age, with 14 of the 23
admissions (60.9%) being between 3 and 6 months of age. One
hundred and nine children (95.6%) lived in urban areas 
(p < 0.01). The overall male-to-female ratio was 1.5:1, being
similar for inpatient admissions and outpatients. Follow-up
was achieved in 91 subjects (80%), with all children recovering.
The major findings of this study were a younger mean age
(7.6 months v. 10.1 months), greater overcrowding (p = 0.002)
and greater indoor exposure to products of combustion of
cooking fuels (p = 0.05) in hospitalised children compared with
those managed as outpatients (Table I). Multivariate analysis
confirmed young age (p = 0.01) and overcrowding (p = 0.02) as
risk factors for hospitalisation. A history of associated atopy or
previous wheezing was significantly more common in children
managed as outpatients compared with those who were
hospitalised (p = 0.04 and p = 0.05 respectively). 
The mode of delivery (normal vaginal or caesarean  section,
2.29:1 v. 2.4:1), gestational age (term or pre-term, 4.66:1 v.
4.75:1) and passive cigarette smoke exposure (39.1% v. 47.3%)
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were not significantly different between those children
admitted and those managed as outpatients. Feeding practices,
viz. exclusive  breast-feeding, bottle-feeding, or mixed feeding,
had no impact on the need to hospitalise patients. Although
birth weight had no impact on the need to hospitalise, all but 4
cases were over 2.0 kg.
Cases of bronchiolitis occurred throughout the year, being
highest between September and November (Fig. 1), with
inpatient admissions occurring  predominantly between
December and March (N = 16). Viruses were identified in 55
cases (48.2%). RSV was identified in 41 cases (74.5%),
parainfluenza 3 in 11 (20.0%), adenovirus in 2, and influenza B
in a single case. The diagnostic yields for shell vial cultures and
rapid monoclonal antibodies test for RSV were similar, with
only 2 cases being positive on monoclonal antibodies and
negative on culture due to delay in inoculation into culture.
Viral isolation was associated with increased risk of
admission (26.7% v. 13.8%, p = 0.08). RSV was isolated
throughout the year, but was associated with increased
inpatient admission rates between December and March 
(Fig. 1) (the summer months). Parainfluenza 3 infections were
predominantly identified between July and November (N = 11)
(winter) and responsible  for 3 admissions during that period.
Blood cultures were positive in 3 of the 23 children admitted.
Staphylococcus epidermidis (N = 2) and Corynebacteria species 
(N = 1) were identified. Nasopharyngeal swabs for bacteria
revealed dual infections (Streptococcus pneumoniae and
Haemophilus influenzae) in 4 cases, isolated H. influenzae and S.
pneumoniae in 4 and 2 cases respectively, and no bacterial
growth in 13 cases. Dual bacterial and viral infections were
seen in 6 cases, 4 cases had bacteria only (S. pneumoniae and H.
influenzae), 4 had viruses alone (RSV) and in 9 cases no
pathogen was detected.
RSV-specific CTL responses and CD4/CD8 ratios
RSV-specific CTL responses were obtained in 21 cases.
Permission to draw blood was refused in 17 cases, while the
remaining 3 children had low total white cell counts that
prohibited CTLanalysis. In 14 of the 21 cases (66.7%) no
responses  could be identified. In the remaining 7 subjects, the
average spot colony forming units per millilitre of PBMC for
the F, M matrix, SH, NS and the NPproteins were 233, 218, 180,
166 and 120  respectively. There were no changes in the CTL
responses on day 7. The  highest frequency of CTLwas
directed against matrix protein ‘M4/5/6’, with a count of 400
sfc/million PBMC. This was the immunodorminant epitope
response in 3 of the 4 patients who responded to the matrix
proteins. The mean CD4/8 ratio for children  where CTL
responses were obtained was  2.27:1 (standard deviation (SD)
1.33), which is within the normal range for similarly aged
children.
Clinical findings and management
Temperature fluctuations were recognised in 42 children
(36.9%) but were not associated with increased risk of
admission. The mean respiratory rates for all subjects were
56.9/min (37 - 98/min), being the same in those admitted and
those treated as outpatients. The mean oxygen  saturation was
94.5% (85 - 99.5%); all children with oxygen saturations below
92% (N = 13) required  admission. Respiratory distress was
seen in 112 children (98.1%), hyperinflation in 57 (50%) and
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Table I. Epidemiological risk factors associated with severity of bronchiolitis (range)
Overall Admissions Outpatients
Category (N = 114 (%)) (N = 23 (%)) (N = 91 (%)) p-value
Mean age (months) 9.1 (3 - 23) 7.6 (3 - 20) 10.1 (3 - 23)
History of atopy 44 (38.6) 4 (17.4) 40 (44) 0.036
Overcrowding (> 2 per room) 69 (60.5) 23 (87.0) 46 (50.5) 0.002
Noxious cooking fuels* 36 (31.6) 11 (47.8) 25 (26.8) 0.050
Previous wheezing 51 (45.7) 6 (26.1) 45 (49.4) 0.045













                   
   
   
 
Fig. 1. Pattern of presentation of RSV-related bronchiolitis.
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crackles in 46 (40%). No child had a decreased level of
consciousness and all children received humidified oxygen.
Nebulisations with an anticholinergic agent alone were utilised
in 74 cases (64.9%), a b2-agonist alone in 16 cases (14.0%), a
combination of b2-agonist and anticholinergic in 22 (19.3%),
and adrenaline in 2 (1.8%). Antibiotics were given  in 38 cases
(33.3%), cough mixtures in 9 (7.9%) and antipyretics in 11
(9.6%) children. Corticosteroids were not utilised in this cohort.
Discussion
The most striking finding of this study was the weak or absent
RSV-specific  CTL responses in apparently immunocompetent
children with RSV bronchiolitis. There is no clear reason why
this should be the case as epitopes directed against the NP, M
SH, NS2 and F proteins of RSV here have elicited CTL
responses in adults.14 This lack of response may be related to
several factors, viz. the limited investigation of PBMCs, the
redistribution of the T-lymphocyte subsets between the
intravascular compartment and the lung parenchyma, or a
different immunopathology mechanism of RSV injury.15 Other
possibilities include the use of peptides based on the wrong
sequence of virus, or helper responses that are not so easily
detectable using Elispot assays. Also, these low-frequency
responses (< 400 sfc/million) may yet be significant in control
of infection. The lack of substantial changes in CTL responses
over the follow-up period suggest a more prolonged effect of
these cells and may be important in future study design.
We have shown that young age, overcrowding, and exposure
to products of fuel combustion during food preparation
(kerosene) were associated with increased risk of
hospitalisation. Alterations in these factors may reduce the
need for hospitalisation. Birth-related factors, feeding practices
and passive cigarette smoke exposure were not associated with
the need for admission, which is unlike the findings of other
studies where prematurity carried a 70 - 75% risk of hospital
admission and a 25% risk of admission to an ICU.5
The higher RSV-related admissions between December and
March have been seen in other tropical regions such as the
Gambia.16 Studies from Argentina and the USAhave confirmed
a predominant winter peak, with the disease occurring mainly
in infants under 1 year of age and carrying a mortality of 
0.5 - 1.5%.2,17 The isolation of RSV throughout the year may be
explained by the concurrent HIV epidemic in this population.
HIV infection has been recognised to prolong carriage of
RSV.18,19 Despite very high clinical suspicion of HIV disease in
this population we were unable to detect any clinical markers
suggestive of HIV infection, although HIV testing was not
performed.
Pulse oximetry provided the best predictor of the need for
hospitalisation. Temperature aberrations and respiratory rates
were not predictive of the need for hospitalisation. This is
unlike the findings of a UK study where fever (> 37.8°C) was
associated with a more severe clinical course and more
radiological changes and the need for hospitalisation.20
Several limitations regarding usefulness of this study remain.
The small sample size, the evaluation of CTL response at just
two time points and the lack of patients with high risk for
severe RSV disease may have contributed to the low frequency
of CTL responses. However, CTL evaluations and identification
of the appropriate epitopes for RSV disease in its infancy are
extremely expensive.
In conclusion, the primary pathogenic and protective
mechanisms against RSV infection require further evaluation.
This study provides knowledge on the risk factors associated
with increased likelihood of admission for bronchiolitis.
Avoidance of overcrowding and provision of adequate
ventilation to areas of the home where food preparation occurs
may reduce the burden of this disease on children in
developing countries.
We would like to thank the Ethics Committee of the University
of Natal, the Medical Superintendent of King Edward VIII
Hospital, Durban, and the patients who participated in this study.
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